Individuals Stopping Anti-Obesity Medications Regain Pounds Far More Rapidly Compared to People Using Diet and Exercise

Fresh analysis indicates that patients who come off new slimming jabs like Mounjaro or Wegovy tend to recover lost weight at a significantly accelerated pace than those who stop traditional lifestyle plans.

Published data in a leading medical journal points out that while overweight people frequently drop substantial amounts of their total mass while on the medication, the weight comes back at an estimated rate of 0.8 kg per month once they quit.

"Individuals using such medications must be aware of the potential of rapid weight regain when the medication concludes," warns lead investigator Dr. Susan Jebb.

Such speed of recovery suggests a return to starting weight in about 18 months.

Weighing Therapies

The research, which reviewed 37 of studies involving over 9,000 of patients, contrasted the effects of the injectable medications with other pills.

Scientists note that individuals who lose weight through dieting typically see a more gradual weight regain—around 0.1 kg a month—post-intervention.

Explaining the Fast Rebound

Experts suggest the way of the jabs is key to understanding the accelerated rebound.

The injections imitate a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.

"Artificially providing the hormone concentrations several times higher than the body's typical production could lead to the body to generate a reduced amount of its endogenous hormone, and could reduce responsiveness to its effects," said Dr. Adam Collins, a dietetics specialist.

"Stopping of this GLP-1 'fix' means hunger is unsuppressed, making overeating a significant risk."

An Ongoing Condition?

The NHS recommend the injections for people with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.

Professionals argue that, given the likelihood of weight regain, the treatment is often ongoing.

This perspective is supported by drug manufacturers, who note that the results "underscore the persistent nature of excess weight," comparing it to managing conditions like high blood pressure.

Patient Testimonies

Individuals who have discontinued the medication describe a intense resurgence of hunger.

"I experienced a trigger that goes on and I was suddenly ravenous," recalled a patient.

The struggle is worsened if users have not developed permanent lifestyle or habit changes during treatment.

Growing Interest

Recent estimates suggest that millions of people in the UK have used these injections in the past year, with demand continuing to grow.

• Use is more common among females than males.
• The middle-aged demographic shows the greatest level of interest.
• A large proportion obtain the medications through private prescriptions rather than public health services.

In conclusion, experts caution that while the jabs are potent agents for weight loss, they are not a magic fix and lasting health benefits likely depends on combined behavioural support.